Virtu Financial LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 74 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$153
+15.0%
15,795
-48.8%
0.01%
-33.3%
Q4 2022$133
-99.9%
30,873
+49.4%
0.02%0.0%
Q2 2022$208,000
-15.4%
20,658
+4.1%
0.02%0.0%
Q1 2022$246,000
-71.7%
19,853
-70.4%
0.02%
-78.8%
Q2 2021$870,000
+111.2%
67,123
+230.2%
0.08%
+112.5%
Q4 2019$412,000
+237.7%
20,326
-10.8%
0.04%
+300.0%
Q3 2019$122,000
+16.2%
22,788
+47.4%
0.01%
+66.7%
Q4 2018$105,000
+6.1%
15,458
-11.7%
0.01%
+50.0%
Q2 2018$99,000
-57.3%
17,511
-52.7%
0.00%
-63.6%
Q3 2017$232,00037,0090.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders